# Exelixis Presents at Healthcare Innovation Conference

> Exelixis shares strategy for zanza drug as it transitions from cabo to future healthcare focus.
- Title: Exelixis Presents at Healthcare Innovation Conference
- Summary: Exelixis shares strategy for zanza drug as it transitions from cabo to future healthcare focus.
- Keywords: exelixis, zanza, cabo, guggenheim healthcare innovation confere, third annual guggenheim healthcare innov, exelixis inc, Seekingalpha
- Source: Seekingalpha — https://seekingalpha.com/article/4965838-exelixis-inc-exel-presents-at-3rd-annual-guggenheim-healthcare-innovation-conference
- Published: 2026-11-10T18:20:55+00:00
- Read time: 1 min
- Topics: exelixis, zanza, cabo, guggenheim healthcare innovation confere, third annual guggenheim healthcare innov, exelixis inc, money, business
## Exelixis Strategy Update
Exelixis presents its transition from cabo to zanza as the long-term healthcare focus.
## Third Annual Conference
Exelixis shares third annual guggenheim healthcare innovation conference presentation details.
## Zanza Drug Focus
Exelixis highlights zanza as the future healthcare solution after cabo's 2020s role.
## Key takeaway

Exelixis describes shifting from cabo to zanza as its long-term healthcare strategy.